Medistim ASA (FRA:MD1)

Market Cap	403.01M
Revenue (ttm)	56.51M
Net Income (ttm)	12.15M
Shares Out	n/a
EPS (ttm)	0.66
PE Ratio	33.16
Forward PE	28.94
Dividend	0.51 (2.53%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	200
Open	21.50
Previous Close	21.30
Day's Range	21.50 - 22.30
52-Week Range	11.10 - 24.40
Beta	n/a
RSI	50.03
Earnings Date	Apr 9, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MD1

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK